Fig. 2From: Role of serum cathelicidin in diagnosis of patient with prostatitis and prostate carcinomaROC curve analysis between prostate cancer and control group. The area under the curve (AUC) was 0.751 (95% CI 0.608–0.895) for LL37 (p = 0.004)Back to article page